Pr Laurent Greillier

Spécialité

Onco-pneumologue, expert poumon

Titre

Chef de département

Hôpital

AP-HM Hôpital Nord (Marseille)

Derniers articles

• Alectinib Efficacy Post-Brigatinib Against Advanced ALK+ Non-Small Cell Lung Cancer (BrigALK2-GFPC 02-2019 Study). (12 août 2025)
• Atezolizumab and bevacizumab, with or without radiotherapy, versus docetaxel in patients with metastatic non-small cell lung cancer previously treated with a checkpoint inhibitor and chemotherapy: results from the randomized, phase Ib/II MORPHEUS-Lung study. (4 août 2025)
• Is adjuvant chemotherapy beneficial in NSCLC patients over 75? Insights from a retrospective analysis. (5 juil. 2025)
• Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial. (24 juin 2025)
• Regression of Retinal Metastasis with Combined Chemotherapy and Immunotherapy. (6 juin 2025)